Background and Scope
The device developed by Vietnamese company, MTTS with validation grant from Wellcome Trust.
Our Approach
Partnership mapping and stakeholder engagement with Indian hospital leaders
- Identified and engaged leading hospital chains in India as clinical validation partners, ensuring alignment with institutions known for neonatal innovation and research excellence.
- Established formal partnerships to facilitate in-hospital trials, leveraging institutional expertise in neonatology and supporting robust clinical feedback loops.
Developed a clear, phased commercialization roadmap for the Dolphin CPAP, outlining steps from successful trial completion to initial procurement, in-market awareness, and broader institutional adoption.
Study Output
SMC managed the partnership with leading hospital chain to validate the device and chartered clear and actionable way forward with identified partnerships for MTTS to launch the Dolphin CPAP in India and lay the foundation for scaled-up adoption.